Topics:
Hematologic Malignancies • Medical Oncology • Myeloma • NCI-CCC Tumor Board Question • University of Washington • NCI-CCC Myeloma Tumor Board Question • Multiple Myeloma
For patients who require aggressive debulking in multiple myeloma, what is your preferred chemotherapy regimen and why?
Modified HyperCVAD? V(R)D-PACE? DCEP? Are there any data to favor one over the other?
Answer from: Medical Oncologist at Academic Institution
I don’t think you will find any convincing data to guide any particular approach. It’s important to note that VD-PACE like regimens, while effective in many ‘hairy’ circumstances, are quite toxic and the decision to move ahead should not be taken likely.
The usual situa...
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
This is excellently stated on all fronts - I compl...
This is excellently stated on all fronts - I compl...
Medical Oncologist at University of Chicago
I dose cyclophosphamide 2 g/m² in two doses, ...
I dose cyclophosphamide 2 g/m² in two doses, ...
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Thank you, this is very helpful - likely the simpl...
Thank you, this is very helpful - likely the simpl...
Medical Oncologist at Virginia Mason Medical Center
For upfront therapy and assuming adequate renal fu...
For upfront therapy and assuming adequate renal fu...
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Completely agree with this excellent clarification...
Completely agree with this excellent clarification...
Medical Oncologist at Winship Cancer Institute of Emory University
Along @Ben Derman's thoughts, remember that VDT-PA...
Along @Ben Derman's thoughts, remember that VDT-PA...
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Very well stated, @Craig C. Hofmeister - hear hear...
Very well stated, @Craig C. Hofmeister - hear hear...
Love this, and completely agree! Every patient who...